A detailed history of New York State Common Retirement Fund transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 24,113 shares of VERA stock, worth $1.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,113
Previous 25,604 5.82%
Holding current value
$1.12 Million
Previous $926,000 15.12%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$34.09 - $46.71 $50,828 - $69,644
-1,491 Reduced 5.82%
24,113 $1.07 Million
Q2 2024

Jul 31, 2024

BUY
$33.72 - $48.82 $391,725 - $567,141
11,617 Added 83.06%
25,604 $926,000
Q1 2024

May 07, 2024

SELL
$14.91 - $49.14 $52,244 - $172,186
-3,504 Reduced 20.03%
13,987 $603,000
Q4 2023

Feb 01, 2024

BUY
$9.29 - $16.0 $58,006 - $99,904
6,244 Added 55.52%
17,491 $269,000
Q3 2023

Nov 07, 2023

BUY
$13.71 - $19.64 $2,550 - $3,653
186 Added 1.68%
11,247 $154,000
Q2 2023

Aug 07, 2023

BUY
$6.11 - $17.83 $293 - $855
48 Added 0.44%
11,061 $178,000
Q4 2022

Jan 30, 2023

SELL
$15.74 - $22.19 $47 - $66
-3 Reduced 0.03%
11,013 $213,000
Q3 2022

Nov 08, 2022

BUY
$13.27 - $22.31 $451 - $758
34 Added 0.31%
11,016 $235,000
Q2 2022

Aug 04, 2022

SELL
$12.82 - $23.4 $12 - $23
-1 Reduced 0.01%
10,982 $149,000
Q1 2022

May 05, 2022

BUY
$17.8 - $28.06 $78,925 - $124,418
4,434 Added 67.7%
10,983 $258,000
Q4 2021

Feb 02, 2022

BUY
$15.01 - $35.8 $80,288 - $191,494
5,349 Added 445.75%
6,549 $175,000
Q3 2021

Nov 02, 2021

BUY
$13.71 - $30.6 $16,452 - $36,720
1,200 New
1,200 $21,000

Others Institutions Holding VERA

About Vera Therapeutics, Inc.


  • Ticker VERA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,042,300
  • Market Cap $1.25B
  • Description
  • Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...
More about VERA
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.